SZSE Ticker: 002317

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

广东众生药业股份有限公司

众生药业

ZHONGSHENGYAOYE

Listing Date: 2009-12-11

Board: SME

Industry Classification: Manufacturing

Zhongsheng Pharmaceutical was investigated by 13 institutions: Fufang Xueshuantong Capsule and Naoshuantong Capsule strengthened evidence-based evidence through medical research and obtained high-quality clinical research results (with survey questions and answers)

Post date May 20, 2022 — 16:00 Post Lock

The Genesis Index rose 1.06% in half a day! Auto sector strengthens Stock Channel Hexun.com

Post date May 17, 2022 — 13:50 Post Lock

The Genesis Index rose 1.06% in half a day! Auto sector strengthens

Post date May 17, 2022 — 12:45 Post Lock

Hepatitis concept, new crown treatment, traditional Chinese medicine and other pharmaceutical stocks fell

Post date May 17, 2022 — 10:27 Post Lock

The main capital of 32.2 billion has withdrawn from the concept stocks of margin financing and securities lending in the past three days – yqqlm

Post date May 16, 2022 — 19:26 Post Lock

The balance of the two financing fell slightly, a decrease of 1.114 billion yuan compared with the previous trading day_Oriental Fortune Net

Post date May 16, 2022 — 12:08 Post Lock

The Shanghai Stock Exchange has known it for a long time │ the central bank has expanded its recruitment to support just-needed house purchases! Economics experts suggest issuing consumer coupons! The first C919 is nearing delivery and its maiden flight test is successful! India restricts wheat exports

Post date May 16, 2022 — 10:53 Post Lock

On May 16th, 6 shares pre-market favorable announcement express CFi.CN Zhongcai Network

Post date May 16, 2022 — 09:05 Post Lock

Pre-market news丨India bans wheat exports; Shanghai will promote the resumption of business and market in stages from today and these important news – yqqlm

Post date May 16, 2022 — 09:05 Post Lock

India bans wheat exports; Shanghai will resume business and market in stages from today… There are more important news

Post date May 16, 2022 — 09:05 Post Lock

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

[China Securities Pre-market] "A Eats A" Reappears! "Yamao" acquired Heren Technology; the central bank lowered the mortgage interest rate; Zhongsheng Pharmaceutical's new crown drug clinical trial was approved jqknews

Post date May 16, 2022 — 07:25 Post Lock

Oral Anti-COVID-19 Innovative Drug Clinical Trials Approved

Post date May 16, 2022 — 03:32 Post Lock

Clinical trials of innovative oral anti-COVID-19 drugs approved

Post date May 16, 2022 — 02:53 Post Lock

New crown oral drug clinical trial approved! Chinese medicine doubled the application of bull stocks after four days, and then made good profits, and institutions fled at high levels – yqqlm

Post date May 15, 2022 — 23:27 Post Lock

Highlights of important announcements of listed companies on May 16: Tongce Medical intends to acquire 29.75% of Heren Technology

Post date May 15, 2022 — 23:23 Post Lock

On the evening of May 15th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

Post date May 15, 2022 — 23:15 Post Lock

Evening Announcements May 15 These announcements are worth seeing

Post date May 15, 2022 — 22:33 Post Lock

Evening Announcement Hotspot Tracking: The relocation of the Asian Cup will have a greater impact on ST Mingcheng – yqqlm

Post date May 15, 2022 — 21:42 Post Lock

Oral Anti-COVID-19 Innovative Drug Clinical Trials Approved

Post date May 15, 2022 — 21:38 Post Lock

Want to see more data? Registered subscribers can see all the data.